Ind-Swift Laboratories is currently trading at its upper limit of Rs. 86.90, up by 4.10 points or 4.95% from its previous closing of Rs. 82.80 on the BSE.
The scrip opened at Rs. 82.00 and has touched a high and low of Rs. 86.90 and Rs. 82.00 respectively. So far 83193 shares were traded on the counter.
The BSE group 'B' stock of face value Rs. 10 has touched a 52 week high of Rs. 86.90 on 14-Jun-2018 and a 52 week low of Rs. 31.00 on 11-Aug-2017.
Last one week high and low of the scrip stood at Rs. 86.90 and Rs. 67.50 respectively. The current market cap of the company is Rs. 409.10 crore.
The promoters holding in the company stood at 54.80%, while Institutions and Non-Institutions held 0.77% and 44.43% respectively.
Ind-Swift Laboratories has raised Rs 424.5 crore through the allotment of 4245 Secured Rated Listed Redeemable Non Convertible Debentures (NCDs) of face value of Rs 10,00,000 each to investors whose bids are accepted through EBP Mechanism. The date of Allotment is June 13, 2018 and interest/ coupon rate is 10%. The tenure of allotment is 6 years. The Board of Directors in their meeting held on June 13, 2018, approved the same.
Ind-Swift Laboratories has manufacturing sites at 6 different locations across India and an independent State-of-the-Art R&D Centre, the Group has embarked upon a journey to establish itself as reliable partner in the Global Pharmaceutical Industry.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1515.25 |
| Dr. Reddys Lab | 6241.60 |
| Cipla | 1480.95 |
| Zydus Lifesciences | 1063.45 |
| Lupin | 1584.30 |
| View more.. | |
MoneyWorks4Me rating and ranking of funds for SIP is available to subscribers only. Moneyworks4Me is not a rating and ranking agency, however it is required that users have a way of selecting funds and building a Portfolio. The method used by it are described below to enable users to understand the logic behind the rating and ranking Subscriber will find more details on this in the various content made available from time to time. In case you need more please write to besafe@moneyworks4Me.com
MoneyWorks4Me rates and ranks mutual funds based on the following data-driven system:
Funds ranking in screeners: Performance Consistency and Quality are two parameters used for ranking funds for SIP. The ranking as follows GG, GO, GR, OG, OO, OR, RG, RO and RR.
With the same color-coded funds, the one with the higher Average 3-year rolling returns (over 5 to 10 years), the number that appears in the Performance tag, ranks higher.
Here is the summary:
The third tag Upside Potential is not relevant for SIP. It is relevant for lumpsum investments in Mutual Funds.
Buy quality Stocks when they are available at reasonable prices and supported by an upward price trend and Sell when they are Overvalued using the Decizen Rating System. Covers 3500+ stocks
Download APP
